JP2010155012A - Eye mask - Google Patents

Eye mask Download PDF

Info

Publication number
JP2010155012A
JP2010155012A JP2009000005A JP2009000005A JP2010155012A JP 2010155012 A JP2010155012 A JP 2010155012A JP 2009000005 A JP2009000005 A JP 2009000005A JP 2009000005 A JP2009000005 A JP 2009000005A JP 2010155012 A JP2010155012 A JP 2010155012A
Authority
JP
Japan
Prior art keywords
body
eyes
covering
carbon fiber
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009000005A
Other languages
Japanese (ja)
Inventor
Hidefumi Aida
Murat Dogru
Kazuo Tsubota
ドール ムラト
一男 坪田
英文 相田
Original Assignee
Therath Medico Kk
セラスメディコ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therath Medico Kk, セラスメディコ株式会社 filed Critical Therath Medico Kk
Priority to JP2009000005A priority Critical patent/JP2010155012A/en
Publication of JP2010155012A publication Critical patent/JP2010155012A/en
Application status is Pending legal-status Critical

Links

Images

Abstract

PROBLEM TO BE SOLVED: To achieve an eye mask for obtaining a medical effect such as the heeling of dry eyes or blepharitis and a beauty effect such as lift-up.
SOLUTION: The eye mask includes a belt-like body 1 of a length for covering both eyes and side head part of the head part of a human body and a means for mounting the body to a face, wherein a vegetable carbon fiber layer is equipped inside the body. By accelerating the bloodstream of capillary blood vessels reaching meibomian glands by the action of vegetable carbon fibers, abundant nutritions and oxygen are given to the meibomian glands, and waste can be carried away. Thus, the meibomian glands can regain a normal function inside the human body for the first time, and the dry eyes and the blepharitis are healed.
COPYRIGHT: (C)2010,JPO&INPIT

Description

この発明は人体の顔面に装着することにより、ドライアイや眼瞼炎の治癒などの医療効果やリフトアップなどの美容効果を得られる眼覆に関する。 By this invention to be mounted on a human body facial relates Mekutsugae obtained a cosmetic effect such as medical effect and lifts up such healing of dry eye or blepharitis.

目の緊張による目の周りの筋肉や血管の収縮が原因で、涙腺やマイボーム腺の機能障害を引き起こす症状をドライアイという。 Contraction of the muscles and blood vessels around the eyes by the eye of the tension is due to the symptoms that leads to the dysfunction of the lacrimal and meibomian glands called dry eye. ドライアイは、テレビやパソコンの画面による目の酷使、冷暖房による異常な不自然な乾燥、コンタクトレンズの装着などが原因で起こり、レーシック手術後に起こることもある。 Dry eye, overuse of the eyes due to television or computer screen, heating and cooling due to abnormal unnatural drying, occur for reasons such as contact lens wear, there is also what happens after LASIK surgery. 乾燥した眼球が瞼の内側の皮をこすり落として眼瞼炎を引き起こすこともある。 Dry eye is sometimes cause blepharitis scraped off the inside of the skin of the eyelid.

ドライアイの治療法としては、涙に近い成分の人工涙液やヒアルロン酸を主成分とする目薬を点眼したり、コンタクトレンズを装着している場合は、コンタクトレンズ用の目薬を点眼したり、あるいは涙点プラグを装着することが一般的である。 The treatment of dry eye, or ophthalmic eye drops mainly containing artificial tears or hyaluronic acid near the tear components, if wearing the contact lens, or instilled eye drops for contact lenses, Alternatively it is common to mount the punctal plug.

一方、固形化されたマイボーム腺の分泌物を溶かし、涙液層を正常な状態に保つためにヒーターを内装した眼覆により眼瞼を温める発明(特許文献1)や、同じく水蒸気を発生する眼覆により水蒸気を目に供給する発明(特許文献2)が公知である。 On the other hand, dissolved secretions solidified meibomian glands, invention to warm the lid by covering the eye was furnished a heater to keep the tear film to a normal state (Patent Document 1) and to also generate steam Mekutsugae invention supplies steam to the eyes (Patent Document 2) are known from.

特願2000−225141公報 Japanese Patent Application No. 2000-225141 Publication 特願2002−78727公報 Japanese Patent Application No. 2002-78727 Publication 特願2004−223188公報 Japanese Patent Application No. 2004-223188 Publication 特願2007−204886公報 Japanese Patent Application No. 2007-204886 Publication 特願2008−222149公報 Japanese Patent Application No. 2008-222149 Publication 特願2008−6132公報 Japanese Patent Application No. 2008-6132 publication

しかしながら、今までの治療方法は、あくまでもドライアイという症状に対する一時的対症療法に過ぎなかった。 However, a method of treatment of up to now, did not last only a temporary symptomatic treatment for the symptoms of dry eye.

一方、特許文献に記載の発明は温熱や水蒸気など外からの作用によりマイボーム腺の分泌物を溶かす点においてはやはり対症療法的であり、また、ヒーターや水蒸気発生装置を組み込まなければならないので眼覆の構造が大がかりになり製造コストが嵩む問題もあった。 On the other hand, the invention described in patent document is still symptomatic in that dissolve secretions of the meibomian gland by the action of the external such as heat or steam, also, since it must incorporate a heater or steam generator Mekutsugae the cost of the structure is to large-scale production increase problem was.

この発明は以上の従来技術の問題点に鑑みて創作されたものであり、一時的対症療法ではなく、生体内の目の周りの毛細血管の血流をきちんと改善することを企図したものであり、原因となる緊張を取り除き、マイボーム腺などの分泌腺の機能障害を正常化することによりドライアイや眼瞼炎を治癒する眼覆を提供することを目的とする。 This invention has been made in view of the above problems of the prior art, not a temporary symptomatic therapy, which was intended to improve proper blood flow capillary around the eyes in vivo , remove the cause tension, an object of the present invention is to provide a covering eye to heal dry eye and blepharitis by normalizing the dysfunction of glands, such as meibomian glands.

すなわち、この発明の眼覆は人体の頭部の両眼および側頭部を覆う長さの帯状の本体と、本体を顔面に装着する手段を有し、上記本体内には植物性炭素繊維層を内装したことを特徴とする。 That is, the belt-shaped body of the eye covering the binocular and cover the temporal length of the human head to the invention includes means for attaching the body to the face, vegetable carbon fiber layer within the body It is characterized in that the interior of the.

また、ここでは前記の眼覆において、両眼に位置する箇所の植物性炭素繊維層を他の部分より厚く構成し、本体の裏側に突起させた眼覆も第2発明として開示する。 Further, in this case the eye covering, vegetable carbon fiber layer of a portion located in both eyes thicker configuration than the other portions, covering the eyes were projections on the back side of the body is also disclosed as a second invention.

この発明の眼覆は植物性炭素繊維層を内装しているが、セルロース系の有機物から作られた織物を炭化させ製造した植物性炭素繊維材料を人体に近づけると、血液中で連鎖的に結合した赤血球同士が分離するとともに正常な丸型の赤血球に戻ると共に、さらに血球に変容性と変形能が出て、赤血球が血管内を互いに独立した状態で流れるようになり血流が促進されることが知られている(特許文献3、4、5)。 Although the eye covering are furnished vegetable carbon fiber layer of the present invention, the closer the vegetable carbon fiber material produced by carbonizing a fabric made from cellulosic organic material in the human body, a chain coupled in blood with red cell each other and return to normal round of red blood cells with separated, further out deformability and transformation of the blood cells, the blood flow would be flowing in a state in which red blood cells are independent within the vessel with each other is promoted is known (Patent documents 3, 4 and 5).

マイボーム腺(マイボームせん、Meibomian gland)は瞼の縁にある特殊な皮脂腺の一つで、目の涙液膜の蒸発を防ぎ、涙が頬にこぼれ落ちるのを防止し、閉じた瞼内を気密にする働きを持つ油性物質(皮脂)の供給をつかさどる。 Meibomian glands (not Meibomian, Meibomian gland) is one of the special sebaceous glands at the edge of the eyelid, to prevent evaporation of the eye of the tear film, tear can be prevented from spilling on the cheek, hermetically closed in the eyelids It has a function to govern the supply of oily substances (sebum). 瞼板腺(けんばんせん、tarsal g1ands)ともいう。 Tarsal glands (Kenbansen, tarsal g1ands) also referred to. マイボーム腺は上瞼には約50本、下瞼には約25本存在する。 Meibomian gland about fifty on the upper eyelid, present from about 25 present on the lower eyelid. 機能障害を起こしているマイボーム腺は、その周りの毛細血管の血流が少なくなっているか、または滞っており、それによりドライアイが引き起こされる。 Meibomian gland undergoing dysfunction, or blood flow in capillaries around it is low, or is stuck, whereby the dry eye is caused.

よって、そのマイボーム腺に到達している毛細血管の血流を前記の植物性炭素繊維の作用により促進させることにより、豊富な栄養と酸素をマイボーム腺に与え、老廃物を運び出すことが可能となり、そのことによって初めて人体内でマイボーム腺が正常な機能を取り戻せるようになり、ドライアイや眼瞼炎が治癒される。 Therefore, by promoting the action of the blood flow in capillaries has reached its meibomian glands the vegetable carbon fiber, gives a rich nutrients and oxygen to the meibomian glands, it is possible to carry away waste products, meibomian glands become regain normal function for the first time in the human body by the, dry eye and blepharitis is healing.

ところで、通常、「アイマスク」と呼ばれている眼覆は、その名の通り人体の頭部の両眼部分のみを覆う大きさおよび形状となっている。 By the way, usually, Mekutsugae that have been referred to as the "eye mask" is, and has a size and shape that covers only the eyes part of the street the body of the head of its name. また、一般的には毛細血管の血流を促進させるためにはマイボーム腺など、対象となるところの上にのみ前記の植物性炭素繊維を当てることが望ましいように思われている。 Also, generally in order to promote blood flow capillaries such meibomian glands, it is thought only to be desirable to apply the vegetable carbon fibers on a place of interest.

しかしながら、臨床試験によると、血流促進をしたい毛細血管の前のより太い血管に植物性炭素繊維を当てると毛細血管の血流が飛躍的に改善されることが確認されている。 However, according to clinical trials, blood flow in capillaries has been confirmed to be greatly improved when exposed to vegetable carbon fiber thicker blood vessels before capillary to be blood flow promotion. この発明の眼覆は、両眼部分のみを覆う公知の眼覆とは異なり、両眼および側頭部を覆う長さの帯状の本体に植物性炭素繊維層を内装している。 Covering the eyes of the present invention, unlike the known eye covering covering only binocular portion, and interior vegetable carbon fiber layer in a strip of the body length to cover the eyes and temporal. よって、瞼の毛細血管の手前、眉間部分の血管血流促進を行うように植物性炭素繊維層が位置する他、頚部から側頭部の頚動脈部分にも植物性炭素繊維層が位置して毛細血管の血流が飛躍的に改善され、さらにリンパ液流の促進効果も得られる。 Therefore, before the capillaries of the eyelid, the other located vegetable carbon fiber layer to perform vascular blood flow promoting glabella portion, capillary vegetable carbon fiber layers in the carotid artery portion temporal from the neck is positioned vascular blood flow is dramatically improved, it can be obtained the effect of promoting further lymphatic flow.

一方、植物性炭素繊維層の作用は狭くマイボーム腺に止まらず、眼球周りの他の腺や筋肉に対してもおよぶ。 On the other hand, the action of vegetable carbon fiber layer does not stop in narrow meibomian glands, also extends to other glands and muscles around the eye. すなわち、毛綱血管の血流促進により緊張が緩み、機能が正常化してくる。 In other words, loosening tension by blood flow promotion of MoTsuna blood vessel, function comes normalized. その結果、この発明の眼覆によれば、ドライアイや眼瞼炎の治癒などの医療効果だけでなく、下記の美容効果も得ることができる。 As a result, according to the covering eyes of the present invention, not only the medical effects, such as healing of dry eye and blepharitis, it is possible to obtain beauty effect below.
(A) 目の周りの肌の血流があがる。 (A) skin blood flow around the eyes is increased.
(B) 目じりの皺が薄くなる。 (B) crow's feet wrinkles is reduced.
(C) 目の周りのくすみが取れる。 (C) eyes dullness can be taken around.
(D) 目の下のくまが取れる。 (D) bear under the eyes can be taken.
(E) リフトアップされる。 (E) is lifted up.
(F) 目の周りに張りが出る。 (F) th tension comes around.
なお、顔面の筋肉の緊張を緩め柔軟にすることによりリフトアップなどの美容効果が得られることは特許文献6により知られている。 Incidentally, the cosmetic effects such as lift-up is obtained by a flexible loosen muscle tension facial is known from Patent Document 6.

次に、第2発明においては、両眼に位置する箇所の植物性炭素繊維層を他の部分より厚く構成して本体の裏側に隆起させているが、これにより眼窩付近の凹凸に眼覆が馴染んで密着性が向上し、植物性炭素繊維層の作用がより確かに発揮される効果が得られる。 Then, in the second invention, the vegetable carbon fiber layer of a portion located in both eyes is raised on the rear side of the body is made thicker configuration than the other portions, but thereby Mekutsugae irregularities near the orbit familiar in improved adhesion, the effect of the action of vegetable carbon fiber layer is more surely exhibited obtained.

この発明の眼覆の第1実施例の斜視図。 Perspective view of a first embodiment of the eye covering of the present invention. 同上、要部の断面図。 Ibid., Cross-sectional view of a main part. この発明の眼覆の第2実施例の斜視図。 Perspective view of a second embodiment of the eye covering of the present invention. 同上、要部の断面図。 Ibid., Cross-sectional view of a main part.

図1および図2はこの発明の眼覆の第1実施例を示す図である。 1 and 2 is a diagram showing a first embodiment of covering the eyes of the present invention. 図中符号1は眼覆の本体である。 Reference numeral 1 is a body of Mekutsugae. この本体1は布などにより人体の頭部の両眼および側頭部を覆う長さの帯状に構成され、表地2Aと裏地2Bとの間には植物性炭素繊維層3が内装される構成からなる。 The body 1 is constructed in a strip length to cover the eyes and the temporal of a human head with a cloth, between the outer material 2A and lining 2B from the configuration vegetable carbon fiber layer 3 is furnished Become.

本願発明において、植物性炭素繊維とは前記の特許文献3、4、5において公知のものであり、特許文献5において『「植物性」とは、セルロース系の有機物から構成されたものであることを意図する。 In the present invention it is of a known in the patent literature 3, 4 and 5 of the the vegetable carbon fiber, and "" botanical "in Patent Document 5 are those made up of cellulosic organic material intended to. 植物性炭素繊維は、綿(綿花)、ウバメガシ繊維、竹繊維、その他の天然植物繊維、あるいは材木を原料とし、これらを高温で焼成することにより得られる。 Vegetable carbon fibers, cotton (cotton), phillyraeoides fibers, bamboo fibers, other natural vegetable fibers, or wood as a raw material, obtained by baking them at a high temperature. 植物性炭素繊維から構成される本発明の素材や物品では、化学繊維に炭を練り混ぜたものとは異なり均一な組成構造の繊維を形成している為、シート等への加工が容易である。 The materials and articles of the present invention consists of vegetable carbon fibers, since forming the fibers of uniform composition structure unlike that kneading charcoal chemical fibers, and are readily fabricated in the form of sheets . さらに、炭を素材にする通常の製品が有するデメリット、例えば、加工により生じる炭の特徴や作用の低下等を回避することが可能となる。 Moreover, disadvantages with normal products charcoal material, for example, it is possible to avoid the deterioration or the like of the features and operation of the coal produced by machining. 植物性炭素繊維の分子構造は特に限定されず、例えば、黒鉛質系炭素、非晶質系炭素、これらの中間的結晶構造を持つ炭素等が挙げられる。 The molecular structure of vegetable carbon fiber is not particularly limited, for example, graphite-based carbon, amorphous carbon, carbon or the like with these intermediate crystal structure. また、繊維径は、所望の効果を得られる限り特には限定されないが、例えば、5〜20μm程度、好ましくは7〜15μm程度、より好ましくは7〜11μm程度である。 The fiber diameter is not particularly limited so long as the resulting desired effect, for example, about 5 to 20 [mu] m, preferably about 7 to 15 m, more preferably about 7~11Myuemu. また。 Also. トウを形成してもよく、撚糸されていてもよい。 May form a tow, it may be twisted. 撚糸された炭素繊維束の直径は、所望の効果を得られる限り特には限定されないが、例えば、0.05〜10mm程度、好ましくは0.1〜5mm程度である。 Twisted and diameter of the carbon fiber bundle is not particularly limited so long as the resulting desired effect, for example, about 0.05 to 10 mm, preferably about 0.1 to 5 mm. 』と、定義されているものである。 And "it is one that has been defined. なお、レーヨンなどの再生セルロース繊維も含むことは勿論である。 Incidentally, it is a matter of course also include regenerated cellulose fibers such as rayon.

この発明においては、植物性炭素繊維層3は眼覆の本体1に内装されるが、この実施例においては両眼(図1において仮想線で図中符号Eとして図示している。)に位置する箇所4、4の植物性炭素繊維層を2層とすることにより他の部分より厚く構成し、本体の裏側に隆起させている。 In this invention, the vegetable carbon fiber layer 3 is furnished to the body 1 of Mekutsugae, located in both eyes in this example (illustrated as reference numeral E in phantom in FIG. 1.) thicker structure than the other portions by a vegetable carbon fiber layer portions 4 and 4 a two-layer, thereby ridges on the back side of the body.

以上の眼覆は顔面に装着されるように使用に供されるが、この実施例においては伸縮素材部分5、5を両側に介在させることにより伸縮自在とした本体1の両端に耳に掛止可能な掛止穴6、6を設けることにより、本体を顔面に装着する手段としている。 Although more eye covering is provided for use to be worn on the face, the latching ears at both ends of the body 1 which is telescopic by interposing an elastic material portions 5 and 5 on both sides in this embodiment by providing the engaging hole 6,6 possible, and a means for attaching the body to the face.

図3および図4はこの発明の眼覆の第2実施例を示す図である。 3 and 4 are views showing a second embodiment of covering the eye of the present invention. 図中符号11は眼覆の本体である。 Reference numeral 11 is a main body of Mekutsugae. この本体11は布などにより人体の頭部の両眼および側頭部を覆う長さの帯状に構成され、表地12Aと裏地12Bとの間には実施例1と同様の植物性炭素繊維層13が内装される構成からなる。 The body 11 is constructed in a strip length to cover the eyes and the temporal of a human head with cloth, similar vegetable carbon fiber layer in Example 1 between the outer material 12A and lining 12B 13 There consists of configurations that are interior.

植物性炭素繊維層13は眼覆の本体11に内装されるが、この実施例においても両眼E、Eに位置する箇所14、14の植物性炭素繊維層を2層とすることにより他の部分より厚く構成し、本体の裏側に隆起させている。 Although vegetable carbon fiber layer 13 is furnished to the body 11 of Mekutsugae also binocular E In this example, the other by a vegetable carbon fiber layer two layers of portions 14 and 14 located in the E thicker structure than the portion, which is raised on the rear side of the body.

以上の眼覆は顔面に装着されるように使用に供されるが、この実施例においては本体11を頭部に巻装可能な長さとするとし、例えばベルベットファスナーなどの一組の係着片の一方6Bを本体の一端の裏面に設けると共に、他方6Aを本体の両眼に位置する箇所14の表面に設けることにより、本体を顔面に装着する手段としている。 Although more eye covering is provided for use to be worn on the face, and the wound length capable body 11 to the head in this embodiment, for example, a pair of engaging pieces, such as velvet fasteners one 6B is provided on the back surface of one end of the body of, by providing the other 6A on the surface of the portion 14 located in both eyes of the body, and a means for attaching the body to the face. この場合、係着片は顔面の前方に位置することで、装着がしやすさくなり、また、寝た時の後ろのごつごつした違和感がなくなる作用を得られる。 In this case, engaging pieces that are located in front of the face, Nari rather ease of the mounting, also obtained a rugged sense of discomfort is eliminated action behind when sleeping.

1 (第1実施例の)眼覆の本体 3 (第1実施例の)植物性炭素繊維層 6 掛止穴 11 (第2実施例の)眼覆の本体 13 (第2実施例の)植物性炭素繊維層 6A、6B 係着片 1 (the first embodiment) main body 3 of the eye covering (the first embodiment) vegetable carbon fiber layer 6 engaging hole 11 (the second embodiment) the eye covering of the body 13 (the second embodiment) Plants sexual carbon fiber layer 6A, 6B-engaging piece

Claims (4)

  1. 人体の頭部の両眼および側頭部を覆う長さの帯状の本体と、本体を顔面に装着する手段を有し、上記本体内には植物性炭素繊維層を内装したことを特徴とする眼覆。 Has a body of both eyes and the strip length to cover the side of the head main body of the head, means for mounting the body to the face, the inside the body, characterized in that the interior of the vegetable carbon fiber layer Mekutsugae.
  2. 両眼に位置する箇所の植物性炭素繊維層を他の部分より厚く構成し、本体の裏側に隆起させた請求項1記載の眼覆。 Vegetable carbon fiber layer of a portion located in both eyes thicker configuration than the other portion, the eye of claim 1, wherein were raised on the rear side of the body covering.
  3. 伸縮自在とした本体の両端に耳に掛止可能な掛止穴を設けることにより、本体を顔面に装着する手段とした請求項1または2記載の眼覆。 Ear by providing the latching possible latching hole at both ends of the telescopic and the body, according to claim 1 or 2 wherein the eye covering that a means for attaching the body to the face.
  4. 本体を人体の頭部に巻装可能な長さとし、一組の係着片の一方を本体の一端の裏面に設けると共に、他方を本体の両眼に位置する箇所の表面に設けることにより、本体を顔面に装着する手段とした請求項1または2記載の眼覆。 The human body can be wound length Satoshi head body, provided with one of a pair of engaging pieces on the back surface of one end of the body, by providing the other on the surface of a portion positioned in both eyes of the body, the body the covering eyes according to claim 1 or 2, wherein that the means for mounting to the face.
JP2009000005A 2009-01-03 2009-01-03 Eye mask Pending JP2010155012A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009000005A JP2010155012A (en) 2009-01-03 2009-01-03 Eye mask

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009000005A JP2010155012A (en) 2009-01-03 2009-01-03 Eye mask

Publications (1)

Publication Number Publication Date
JP2010155012A true JP2010155012A (en) 2010-07-15

Family

ID=42573377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009000005A Pending JP2010155012A (en) 2009-01-03 2009-01-03 Eye mask

Country Status (1)

Country Link
JP (1) JP2010155012A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD638128S1 (en) 2009-10-06 2011-05-17 Tearscience, Inc. Ocular device design
US7976573B2 (en) 2006-05-15 2011-07-12 Tearscience, Inc. Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US7981146B2 (en) 2006-05-15 2011-07-19 Tearscience Inc. Inner eyelid treatment for treating meibomian gland dysfunction
US7981147B2 (en) 2006-05-15 2011-07-19 Tearscience, Inc. Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US8007524B2 (en) 2006-05-15 2011-08-30 Tearscience, Inc. Heat treatment and heat loss reduction for treating meibomian gland dysfunction
US8025689B2 (en) 2005-07-18 2011-09-27 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction
US8128673B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8128674B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8137390B2 (en) 2006-05-15 2012-03-20 Tearscience, Inc. System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
US8628504B2 (en) 2005-07-18 2014-01-14 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction employing fluid jet
US8950405B2 (en) 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
US9719977B2 (en) 2005-07-18 2017-08-01 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US9763827B2 (en) 2013-04-30 2017-09-19 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
US9913678B2 (en) 2005-07-18 2018-03-13 Tearscience, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US10092449B2 (en) 2013-04-30 2018-10-09 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
US10376273B2 (en) 2014-10-09 2019-08-13 Tearscience, Inc. Methods and apparatuses for treatment of meibomian glands

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187310B2 (en) 2005-07-18 2012-05-29 Tearscience, Inc. Method and apparatus for treating gland dysfunction
US9216028B2 (en) 2005-07-18 2015-12-22 Tearscience, Inc. Apparatuses for treatment of meibomian glands
US9060843B2 (en) 2005-07-18 2015-06-23 Tearscience, Inc. Method and apparatus for treating gland dysfunction employing heated medium
US8915253B2 (en) 2005-07-18 2014-12-23 Tearscience, Inc. Method and apparatus for treating gland dysfunction employing heated medium
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US8685073B2 (en) 2005-07-18 2014-04-01 Tearscience, Inc. Apparatus for treating meibomian gland dysfunction
US8025689B2 (en) 2005-07-18 2011-09-27 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction
US8083787B2 (en) 2005-07-18 2011-12-27 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction
US8628504B2 (en) 2005-07-18 2014-01-14 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction employing fluid jet
US8187311B2 (en) 2005-07-18 2012-05-29 Tearscience, Inc. Method and apparatus for treating gland dysfunction
US9913678B2 (en) 2005-07-18 2018-03-13 Tearscience, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US9719977B2 (en) 2005-07-18 2017-08-01 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US8007524B2 (en) 2006-05-15 2011-08-30 Tearscience, Inc. Heat treatment and heat loss reduction for treating meibomian gland dysfunction
US8523928B2 (en) 2006-05-15 2013-09-03 Tearscience, Inc. System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8617229B2 (en) 2006-05-15 2013-12-31 Tearscience, Inc. System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8128673B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8632578B2 (en) 2006-05-15 2014-01-21 Tearscience, Inc. System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
US8128674B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US7981147B2 (en) 2006-05-15 2011-07-19 Tearscience, Inc. Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8950405B2 (en) 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US7981146B2 (en) 2006-05-15 2011-07-19 Tearscience Inc. Inner eyelid treatment for treating meibomian gland dysfunction
US7976573B2 (en) 2006-05-15 2011-07-12 Tearscience, Inc. Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
US8137390B2 (en) 2006-05-15 2012-03-20 Tearscience, Inc. System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
USD638128S1 (en) 2009-10-06 2011-05-17 Tearscience, Inc. Ocular device design
US9763827B2 (en) 2013-04-30 2017-09-19 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
US10092449B2 (en) 2013-04-30 2018-10-09 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
US10376273B2 (en) 2014-10-09 2019-08-13 Tearscience, Inc. Methods and apparatuses for treatment of meibomian glands

Similar Documents

Publication Publication Date Title
US2891252A (en) Sleeping device
JP2015503417A (en) Dry eye treatment system
JP5072955B2 (en) Non-invasive method and apparatus for treating neurological disorders by local brain heat stimulation
McFadden et al. Acute effects of dietary retinoic acid on ocular components in the growing chick
Vora et al. Intense pulsed light therapy for the treatment of evaporative dry eye disease
US20080251085A1 (en) Disposable sleep mask for treating dry eye syndrome
CN104306430B (en) A medical dressing biological ocular cold therapy and preparation method
Arden et al. Regression of early diabetic macular oedema is associated with prevention of dark adaptation
Fors et al. Patient education, guided imagery and pain related talk in fibromyalgia coping
Pascotto et al. Neonatal hyperekplexia: a case report
JP6125036B2 (en) The cosmetic composition obtained from hatching fluid of fish
WO2000043070A1 (en) The optical quantum medical technology and the instrument thereof
CN101697955A (en) Eye cream with pearl hydrolyzate liposome
Lasky et al. PHACE syndrome: association with persistent fetal vasculature and coloboma-like iris defect
CN201477298U (en) Spectacle frame
KR101586684B1 (en) Massage device for eyeball
Ricketts et al. A 4-year follow-up of treatment of self-injury
CN104688645A (en) Wrinkle reducing eye cream
CN202376300U (en) Heating health care eyeshade
CN204798346U (en) Stifling eye physiotherapy device of wearing type far infrared ultrasonic wave constant temperature medicine fog
CN102008596B (en) Chinese medicine eye compressing bag for treating myopic eye
CN101766695A (en) Point eye mask and preparation method and application thereof
Falco et al. Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma
CN203506971U (en) Intelligent music steam eye patch with timing function
CN101756849A (en) Beauty cream for removing dark eye circles